Nov 7, 2025

Featuring an interview with Dr Aaron Lisberg, including the following topics:

• Prevention and Management of Adverse Events of Special Interest with Datopotamab Deruxtecan (Dato-DXd) (0:00)
  • Rugo H et al. US expert Delphi consensus on the prevention and management of stomatitis in patients...

Oct 20, 2025

Featuring an interview with Dr Aaron Lisberg, including the following topics:

• Efficacy and Safety of Datopotamab Deruxtecan (Dato-DXd) for Patients with Previously Treated EGFR-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC): A Pooled Analysis of the TROPION-Lung01 and TROPION-Lung05 Trials (0:00)
  • Ahn M-J et...

Sep 12, 2025

Featuring an interview with Dr Jacob Sands, including the following topics:

• Management of Adverse Events of Special Interest Associated with Datopotamab Deruxtecan (Dato-DXd) (0:00)
  • Heist RS et al. Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab...

Aug 22, 2025

Featuring perspectives from Dr Stephen V Liu and Dr Charles Rudin, including the following topics: 

• Introduction (0:00)
• Case 1: Adjuvant Systemic Therapy? (1:15)
• Case 2: Lambert-Eaton Syndrome and Other Paraneoplastic Syndromes (4:16)
• Case 3: Small Cell Transformation of EGFR-Mutant Non-Small Cell Lung Cancer (9:54)

Aug 15, 2025

Featuring an interview with Dr Jacob Sands, including the following topics:

• TROPION-Lung05 Trial: Datopotamab Deruxtecan for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations (0:00)
  • Sands J et al. Datopotamab deruxtecan in advanced or metastatic non-small cell lung cancer...